Related Experiment Videos
Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial
L Sanchez-Ramos1, D E Peterson, I Delke
1Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209, USA.
Obstetrics and Gynecology
|March 10, 1998
Summary
Intravaginal misoprostol is a cheaper and more effective option for labor induction compared to dinoprostone vaginal inserts. While it speeds up delivery, it slightly increases uterine tachysystole risk, though overall safety remains comparable.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Reproductive Medicine
Background:
- Cervical ripening and labor induction are critical in managing various pregnancy complications.
- Intravaginal medications are commonly used to achieve cervical readiness for labor.
Purpose of the Study:
- To compare the safety, efficacy, and cost-effectiveness of intravaginal misoprostol versus dinoprostone vaginal inserts for cervical ripening and labor induction.
Main Methods:
- A randomized controlled trial involving 223 patients undergoing labor induction.
- Patients were assigned to receive either intravaginal misoprostol (50 mcg every 3 hours for up to 24 hours) or a dinoprostone vaginal insert (10 mg for 12 hours).
Main Results:
- Misoprostol significantly shortened the median interval from induction to vaginal delivery (698 vs. 1041 minutes, P < .001).
- Vaginal delivery within 12 hours occurred more frequently with misoprostol (40.7% vs. 19.1%, P < .001).
- Uterine tachysystole was more common with misoprostol (21.3% vs. 7.0%, P = .004), but no significant differences in adverse outcomes were observed.
- Misoprostol treatment averaged $85 per patient, compared to $606 for dinoprostone.
Conclusions:
- Both misoprostol and dinoprostone are safe for cervical ripening and labor induction.
- Intravaginal misoprostol demonstrates superior cost-effectiveness and efficacy in accelerating labor compared to dinoprostone vaginal inserts.